Aikaterini Lymperidou

Aikaterini Lymperidou

Auto-generated profile, based on publicly available information

Aikaterini Lymperidou

Institute for Bioengineering of Catalonia, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
LALorena Alonso
Lorena Alonso
MPMiguel Ángel Pérez-Elena
Miguel Ángel Pérez-Elena
Mohammed Yousef Salem AliMohammed Yousef Salem Ali
Mohammed Yousef Salem Ali
MMMaedeh Mashhadikhan
Maedeh Mashhadikhan
NGNicolás Gaitán
Nicolás Gaitán
DTDavid Torrents
David Torrents
Type 2 diabetes (T2D) is a complex and clinically heterogeneous disease. Although clustering approaches have defined clinical subtypes, their genetic and molecular architectures remain poorly understood. Efforts using genome-wide association studies (GWAS) have been constrained by modest sample sizes and conservative significance thresholds, limiting subgroup resolution. Leveraging recent expansions in cohort scale and diversity, we developed a new analytical framework that integrates GWAS with Machine Learning and eXplainable Artificial Intelligence. Applied to the UK Biobank, this strategy enabled the first comprehensive genetic and molecular characterization of T2D subtypes, identifying 184 genes that define each subgroup’s molecular landscape and associated tissue profiles. In addition, the framework improved detection of T2D risk compared to current Polygenic Risk Scores. The findings underscore the importance of clinical stratification to uncover the complex pathophysiology of T2D and to pave the way for more precise prevention and treatment strategies.

22 August 2024
Verified
Book Chapter
Open access
PDF file
GCGuillem Bracons Cucó
Guillem Bracons Cucó
JRJessyca Gil Rojas
Jessyca Gil Rojas
PMPetter Peñafiel Macias
Petter Peñafiel Macias
XFXavier Borrat Frigola
Xavier Borrat Frigola
ALAikaterini Lymperidou
Aikaterini Lymperidou
SFSantiago Frid
Santiago Frid
Common Data Models (CDMs) enhance data exchange and integration across diverse sources, preserving semantics and context. Transforming local data into CDMs is typically cumbersome and resource-intensive, with limited reusability. This article compares OntoBridge, an ontology-based tool designed to streamline the conversion of local datasets into CDMs, with traditional ETL methods in adopting the OMOP CDM. We examine flexibility and scalability in the management of new data sources, CDM updates, and the adoption of new CDMs. OntoBridge showed greater flexibility in integrating new data sources and adapting to CDM updates. It was also more scalable, facilitating the adoption of various CDMs like i2b2, unlike traditional methods reliant on OMOP-specific tools developed by OHDSI. In summary, while traditional ETL provides a structured approach to data integration, OntoBridge offers a more flexible, scalable, and maintenance-efficient alternative.

22 August 2024
Verified
Book Chapter
Open access
PDF file
ALAikaterini Lymperidou
Aikaterini Lymperidou
JMJudith Martinez-Gonzalez
Judith Martinez-Gonzalez
GCGuillem Bracons Cucó
Guillem Bracons Cucó
SFSantiago Frid
Santiago Frid
Rafael de CidRafael de Cid
Rafael de Cid
ALAlberto Labarga
Alberto Labarga
Transforming the population based biomedical cohort into the Common Data Model (OMOP-CDM) empowers researchers to access direct sources of information, enabling a deeper understanding of how genetic profiles relate to clinical outcomes and providing new knowledge that can significantly influence health care practices around the world.